Bulletin of the Chemical Society of Japan p. 423 - 428 (2000)
Update date:2022-08-04
Topics:
Hasegawa, Tomoyuki
Yamamoto, Hisashi
(R)-2-Propyloctanoic acid has been developed as a novel therapeutic agent for Alzheimer's disease. A large-scale synthesis of this candidate was achieved by using Oppolzer's camphorsultam as a chiral auxiliary under improved conditions. It was essential for the successful synthesis of this compound to utilize a new removal method for the chiral source with a combination of tetrabutylammonium hydroxide and hydrogen peroxide. The present process afforded the desired product in high yield with high optical purity.
View MoreNanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
Hunan Zhongqi Pharmaceutical Co., Ltd
website:http://www.hnzqzy.com
Contact:0730-8722288 13807308622
Address:Wanjiafan Road ,Yueyang Economic And Technological Development Zone ,Hunan,PRC
Contact:0086 16537861366
Address:building 17, shibei district Qingdao, shandong china
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
Doi:10.1246/cl.1998.863
(1998)Doi:10.1002/1522-2675(200206)85:6<1659::AID-HLCA1659>3.0.CO;2-D
(2002)Doi:10.1002/aoc.3298
(2015)Doi:10.1016/S0031-9422(98)00270-2
(1998)Doi:10.1002/hc.21415
(2018)Doi:10.1016/S0040-4020(98)00781-9
(1998)